All Stories

  1. Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion
  2. Corrigendum
  3. The role of galenic innovation in improving treatment compliance and persistence: three case studies